Drug Shortage Report for HYDROMORPHONE HYDROCHLORIDE INJECTION USP

Last updated on 2025-02-12 History
Report ID 225629
Drug Identification Number 02382636
Brand name HYDROMORPHONE HYDROCHLORIDE INJECTION USP
Common or Proper name HYDROMORPHONE HYDROCHLORIDE INJECTION USP
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) HYDROMORPHONE HYDROCHLORIDE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 10x5mL vial
ATC code N02AA
ATC description OPIOIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-06-10
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2025-02-12
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: [email protected]

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2025-02-12 French Compare
v11 2025-02-12 English Compare
v10 2025-01-17 French Compare
v9 2025-01-17 English Compare
v8 2024-10-09 French Compare
v7 2024-10-09 English Compare
v6 2024-06-11 English Compare
v5 2024-06-10 French Compare
v4 2024-06-10 English Compare
v3 2024-06-02 English Compare
v2 2024-04-18 French Compare
v1 2024-04-18 English Compare

Showing 1 to 12 of 12